These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25399713)

  • 41. Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues.
    Gillis NK; Innocenti F
    Clin Pharmacol Ther; 2014 Dec; 96(6):655-7. PubMed ID: 25399714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions.
    Alagoz O; Durham D; Kasirajan K
    Pharmacogenomics J; 2016 Apr; 16(2):129-36. PubMed ID: 25987241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.
    Haga SB; Allen LaPointe NM; Moaddeb J; Mills R; Patel M; Kraus WE
    Pharmacogenomics; 2014 Nov; 15(14):1729-1737. PubMed ID: 25493566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The hidden harm behind the return of results from personal genome services: a need for rigorous and responsible evaluation.
    Janssens AC
    Genet Med; 2015 Aug; 17(8):621-2. PubMed ID: 25412399
    [No Abstract]   [Full Text] [Related]  

  • 46. The potential utility of pharmacogenetic testing in psychiatry.
    Gardner KR; Brennan FX; Scott R; Lombard J
    Psychiatry J; 2014; 2014():730956. PubMed ID: 25587529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The promise of psychiatric pharmacogenomics.
    Hamilton SP
    Biol Psychiatry; 2015 Jan; 77(1):29-35. PubMed ID: 25483343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
    Linares OA; Fudin J; Daly AL; Boston RC
    Clin J Pain; 2015 Dec; 31(12):1026-35. PubMed ID: 25621429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas.
    Dorfman EH; Brown Trinidad S; Morales CT; Howlett K; Burke W; Woodahl EL
    Pharmacogenomics; 2015; 16(3):227-37. PubMed ID: 25712186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Web resources for pharmacogenomics.
    Zhang G; Zhang Y; Ling Y; Jia J
    Genomics Proteomics Bioinformatics; 2015 Feb; 13(1):51-4. PubMed ID: 25703229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.
    Douglas MP; Ladabaum U; Pletcher MJ; Marshall DA; Phillips KA
    Genet Med; 2016 Feb; 18(2):111-6. PubMed ID: 25996638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of contemporary genetics in cardiovascular diagnosis.
    George AL
    Circulation; 2014 Nov; 130(22):1971-80. PubMed ID: 25421045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.
    Lennard L; Cartwright CS; Wade R; Vora A
    Br J Haematol; 2015 Apr; 169(2):228-40. PubMed ID: 25441457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CYP2C19 polymorphism influences Helicobacter pylori eradication.
    Kuo CH; Lu CY; Shih HY; Liu CJ; Wu MC; Hu HM; Hsu WH; Yu FJ; Wu DC; Kuo FC
    World J Gastroenterol; 2014 Nov; 20(43):16029-36. PubMed ID: 25473155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Programs and Discoveries Aim to Combat Antibiotic Resistance.
    Hampton T
    JAMA; 2015 Jun 23-30; 313(24):2411-3. PubMed ID: 26039283
    [No Abstract]   [Full Text] [Related]  

  • 57. [An economic perspective on targeted treatments].
    Seror V
    Med Sci (Paris); 2014 Nov; 30 Spec No 2():32-5. PubMed ID: 25407456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How can psychological science inform research about genetic counseling for clinical genomic sequencing?
    Khan CM; Rini C; Bernhardt BA; Roberts JS; Christensen KD; Evans JP; Brothers KB; Roche MI; Berg JS; Henderson GE
    J Genet Couns; 2015 Apr; 24(2):193-204. PubMed ID: 25488723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
    Goetz MP; Sun JX; Suman VJ; Silva GO; Perou CM; Nakamura Y; Cox NJ; Stephens PJ; Miller VA; Ross JS; Chen D; Safgren SL; Kuffel MJ; Ames MM; Kalari KR; Gomez HL; Gonzalez-Angulo AM; Burgues O; Brauch HB; Ingle JN; Ratain MJ; Yelensky R
    J Natl Cancer Inst; 2014 Dec; 107(2):. PubMed ID: 25490892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic.
    Foley SB; Rios JJ; Mgbemena VE; Robinson LS; Hampel HL; Toland AE; Durham L; Ross TS
    EBioMedicine; 2015 Jan; 2(1):74-81. PubMed ID: 26023681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.